At Interphex2007, Pall launches several new technologies to provide the biopharmaceutical industry with tools and systems to more efficiently manage manufacturing processes
The increasing focus on biotechnology and personalized medicines along with the growth of the vaccine marketplace is changing the face of the biopharmaceutical industry, an $80 billion global market.
Drug manufacturers are challenged by cost pressures, the need for shorter production times and rapid scale-up, as well as bottlenecks in downstream operations.
A leader in filtration, separation and purification, Pall offers a comprehensive line of integrated solutions for biopharmaceutical manufacturers from upstream to downstream applications.
